珠海都市网
您当前的位置 :首页 > 文传商讯 > 正文
Merck Announces Mutual Decision to End Bintrafusp Alfa Agreement With GSK
2021年10月09日 15:31:05来源:作者:

Not intended for UK- US- or Canada-based media

DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced a mutual decision with GSK to terminate their agreement on bintrafusp alfa, effective September 30, 2021.

The decision is based on the clinical trial data generated to date, most notably the previously reported results from the INTR@PID Lung 037 study, which did not replicate the encouraging data observed in earlier studies. Based on the data generated during the agreement, no milestone payments were made by GSK and no future milestone obligations remain.

The INTR@PID clinical program sought to validate the potential of the novel mechanism of simultaneously blocking TGF-ß and PD-L1, with the ambition to improve outcomes for patients with difficult-to-treat cancers. Given the extent of the clinical program, Merck will deepen its scientific leadership in the field and interrogate the data leveraging the power of advanced analytics. The important insights this program has yielded about the biology of TGF-β will inform the collective understanding of this pathway.

Merck is a science-led organization dedicated to delivering transformative medicines with the goal of making a meaningful difference in the lives of people affected by cancer. Our oncology research efforts, comprised of 10 ongoing development programs, aim to leverage our synergistic portfolio in oncogenic pathways, immuno-oncology, and DNA Damage Response (DDR) to tackle challenging tumor types in gastrointestinal, genitourinary, and head and neck and thoracic cancers. Learn more at https://www.merckgrouponcology.com.

All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.

About Merck
Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck generated sales of € 17.5 billion in 66 countries.

Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.

责任编辑: admin

看新闻,关注新闻

天涯网友:永远别回头
评论:世界上最最废话的就是那句写在烟盒上面的“吸烟有害健康”。

猫扑网友:〃失之我命
评论:生活之所以有回忆,不是因为突然想起,而是因为不能忘记!

搜狐网友:Pawonx-爱离殇
评论:世界上最远的距离不是生与死,而是我在新浪微博,而你却在腾讯微博。

其它网友:忘了爱° Toro
评论:世界上没有绝对幸福圆满的婚姻,幸福只是来自于无限的容忍与互相尊重。

凤凰网友:Flowers 繁花
评论:古希腊人说过:能让我笑得人最爱我,能让我哭的人我最爱。

百度网友:Warm| 浅珊瑚
评论:我愿意为你摘一颗星,只要你借给我足够高的椅子。

腾讯网友:Sunny°刺眼
评论:今天情人节出去玩,卖花的小姑娘拉着我:“大哥哥,买花吧,一看就知道你是花心的人”……

网易网友:不了了之 Bulziゅ
评论:人生如同故事,重要的并不是有多长,而是在有多好。

本网网友:ゆ.咬破红唇
评论:我说过我爱你。没说我只爱你。

天猫网友:情是无所不为
评论:白天睡觉觉,晚上打闹闹,有事死翘翘。

相关阅读
分享到:
版权和免责申明

珠海都市网所有文字、图片、视频、音频等资料均来自互联网,不代表本站赞同其观点,本站亦不为其版权负责。相关作品的原创性、文中陈述文字以及内容数据庞杂本站无法一一核实,如果您发现本网站上有侵犯您的合法权益的内容,请联系我们,本网站将立即予以删除!